Progressive Care Achieves Record COVID-19 Testing Revenues
April 05 2021 - 7:10AM
InvestorsHub NewsWire
MIAMI, FL -- April 5, 2021 -- InvestorsHub NewsWire --
Progressive Care Inc. (OTCQB:RXMD)
(“Progressive Care” or the “Company”), a personalized healthcare
services and technology company, is pleased to announce that the
Company has surpassed $1 million in revenues directly driven by its
COVID-19 testing program.
“We are truly grateful for the opportunity to be a part of the
solution and help our community confront what promises to be a
long-term battle with the virus, an elusive and formidable
adversary,” commented Alan Jay Weisberg, CEO and Chairman of
Progressive Care.
During 2020, the Company conducted over 4,700 COVID-19 tests
that resulted in $599k in revenues. For the three months ended
March 31, 2020, the revenue run rate associated with COVID-19
testing has accelerated, with approximately 2,900 tests, resulting
in over $400k in revenues related to testing.
Mr. Weisberg continued, “We have recently added more testing
equipment and analyzers and we hold a market-leading position in
rapid results PCR and antigen-based testing systems. We are looking
forward to continuing to expand our market share in COVID-19
testing throughout Florida State.”
For more information about Progressive Care, please visit the
company’s website. Connect and stay in touch with us on social
media:
Progressive Care Inc.
https://www.facebook.com/ProgressiveCareUS/
https://twitter.com/ProgressCareUS
PharmCoRx
https://www.facebook.com/pharmcorx/
https://twitter.com/PharmCoRx
ClearMetrX
https://www.clearmetrx.com/
https://www.facebook.com/clearmetrx/
About Progressive Care: Progressive Care Inc. (OTCQB:
RXMD), through its subsidiaries, is a Florida health services
organization and provider of prescription pharmaceuticals,
compounded medications, provider of tele-pharmacy services, the
sale of anti-retroviral medications, medication therapy management
(MTM), the supply of prescription medications to long-term care
facilities, and health practice risk management.
Cautionary Disclosure Regarding Forward-Looking Statements
Forward-Looking Statements contained herein that are not based upon
current or historical fact are forward-looking in nature and
constitute forward-looking statements within the meaning of Section
27A of the Securities Act of 1933 and Section 21E of the Securities
Exchange Act of 1934. Such forward-looking statements reflect the
Company’s expectations about its future operating results,
performance, and opportunities that involve substantial risks and
uncertainties. When used herein, the words “anticipate,” “believe,”
“estimate,” “upcoming,” “plan,” “target,” “intend” and “expect” and
similar expressions, as they relate to Progressive Care Inc., its
subsidiaries, or its management, are intended to identify such
forward-looking statements. These forward-looking statements are
based on information currently available to the Company and are
subject to a number of risks, uncertainties, and other factors that
could cause the Company’s actual results, performance, prospects,
and opportunities to differ materially from those expressed in, or
implied by, these forward-looking statements.
Public Relations Contact:
Carlos Rangel
carlosr@pharmcorx.com
Progressive Care (QB) (USOTC:RXMD)
Historical Stock Chart
From Aug 2024 to Sep 2024
Progressive Care (QB) (USOTC:RXMD)
Historical Stock Chart
From Sep 2023 to Sep 2024